Clinical Trial

COR Protocol for the Treatment of Binge Eating in Chilean Adults (COR)

Study acronym: COR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 22, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical study is to learn whether a brief online psychological program called COR can be delivered in a feasible and acceptable way for adults who experience recurrent binge eating. The main questions this study aims to answer are: * Is the COR program acceptable to participants, in terms of satisfaction, adherence, and dropout rates? * Is the COR program feasible to deliver online, including recruitment, retention, and completion of sessions and questionnaires? * Do participants show preliminary changes over time in binge eating-related distress and emotional well-being? Participants in this study are adults who experience recurrent episodes of binge eating. They will take part in an individual online intervention that includes eight weekly sessions, a brief pre-session, and a follow-up session one month after the end of treatment. During the study, participants will: * Attend weekly online sessions focused on understanding binge eating, emotions, and the relationship with food and the body * Practice simple exercises to help manage emotional distress and food-related urges * Complete short questionnaires before, during, and after the intervention to describe their experiences The information from this study will help researchers understand whether this type of intervention can be used in future, larger studies and in real-world clinical settings.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-23
Trial Details
NCT Number NCT07435974
Lead Sponsor Universidad Catolica de Temuco
Collaborators: Agencia Nacional de Investigación y Desarrollo
Conditions Binge Eating Disorder, Binge Eating
Enrollment 30 participants
Start Date 2026-04-01
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-22